Literature DB >> 66295

Mitogenic activity of Actinomyces viscosus. I. Effects on murine B and T lymphocytes, and partial characterization.

D Engel, J Clagett, R Page, B Williams.   

Abstract

Actinomyces viscosus homogenate (AVIS) contins substance(s) which cause spleen cells from conventional and germfree mice to undergo increased DNA synthesis. This mitogenic effect is primarily on B cells since spleen cells from nude mice or T-depleted spleen cells from conventional mice respond as strongly as conventional (T + B) spleen cells. Mouse thymocytes do not respond mitogenically to AVIS. It is unlikely that the mitogenic acitivity is due to the presence of LPS, since A. viscosus is Gram-positive and is not known to have an LPS cell wall component. Also, AVIS is not inactivated by polymyxin B, as are some preparations of LPS, and C3H/HeJ mouse splenocytes respond strongly to AVIS but not to LPS. The activity is heat stable, is not lost upon dialysis, and is not affected by lysozyme. Mitogenic activity is partially lost when AVIS is digested with nonspecific bacterial protease or treated with metaperiodate. Sodium hydroxide treatment completely abolishes mitogenic activity. Actinomycotic lesions are characterized by a long-tern inflammatory response involving a dense plasma cell infiltrate. We suggest that B cell mitogens form Actinomyces may play a role in the elicitation of the plasma cell component of these lesions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66295

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Polyclonal activators in pulmonary immune disease.

Authors:  W F Willoughby; J B Willoughby; G F Gerberick
Journal:  Clin Rev Allergy       Date:  1985-05

2.  Antibody synthesis specific for nonoral antigens in inflamed gingiva.

Authors:  S M Mallison; A K Szakal; R R Ranney; J G Tew
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

3.  Genetic control of mitogen-induced B-cell hyperproliferation in SM/J mice.

Authors:  R Stone; D Engel
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

4.  Studies on the mechanism of peptidoglycan- and lipopolysaccharide-induced polyclonal activation.

Authors:  R Dziarski
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

5.  Identification of the virulence-associated antigen on the surface fibrils of Actinomyces viscosus T14.

Authors:  J O Cisar; A E Vatter; F C McIntire
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

6.  Accumulation of plasma cells in inflamed sites: effects of antigen, nonspecific microbial activators, and chronic inflammation.

Authors:  S M Mallison; J P Smith; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  In vitro stimulation of immunoglobulin production from human peripheral blood lymphocytes by a soluble preparation of Actinomyces viscosus.

Authors:  D F Mangan; D E Lopatin
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

8.  Cell-mediated cytotoxicity against rat fibroblasts induced by Actinomyces viscosus.

Authors:  R Gaegauf-Zollinger; J J Burckhardt; R Gmür; B Guggenheim
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  Role of macrophages in the lymphocyte response to Actinomyces viscosus.

Authors:  R M McCarron; J E Fitzgerald; D C Birdsell
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

10.  Effects of metabolic inhibitors on extracellular fructosyltransferase production in Actinomyces viscosus.

Authors:  W Chak; H K Kuramitsu
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.